European regulators are raising concerns that the uterine fibroid drug Esmya, awaiting approval in the U.S., may be linked to liver damage and liver failure risks.
Tag Archives: Esmya
More Top Stories
The U.S. Navy has received more than 129,000 Camp Lejeune water contamination claims, according to court records.
Reader testimonials highlight the severe tooth damage suffered by many Suboxone users as lawyers pursue product liability lawsuits against the manufacturers.
A Bard PowerPort lawsuit accuses the manufacturers of concealing known defects and complications from patients and the medical community.